CHUNGHWA BIOLOGICAL TECHNOLOGY (PRIVATE) LIMITED

Company Introduction: CHUNGHWA BIOLOGICAL TECHNOLOGY (PRIVATE) LIMITED

CHUNGHWA BIOLOGICAL TECHNOLOGY (PRIVATE) LIMITED is a Pakistani company dedicated to the research, development, production, and marketing of biological products primarily for animal health.

This company is a FACTORY (MANUFACTURER).

It specializes in the manufacturing of a comprehensive range of veterinary biologicals, which includes various vaccines for poultry and other livestock animals. Their product line typically encompasses vaccines designed to combat prevalent animal diseases like Newcastle Disease, Infectious Bronchitis, and other crucial biological preparations aimed at enhancing animal health and productivity within Pakistan's agricultural sector.

Founded with an emphasis on advanced biotechnology, CHUNGHWA BIOLOGICAL TECHNOLOGY holds a significant position in delivering high-quality and effective solutions for the prevention and management of animal diseases, thereby contributing substantially to the livestock industry in Pakistan. The company is recognized for its dedication to scientific research and development to produce biological products that meet high standards.

ChungHwa Biological Technology (Private) Limited in Pakistan manufactures and sells a diverse range of pharmaceutical products. Their portfolio typically includes various therapeutic categories such as antibiotics, analgesics, antipyretics, anti-inflammatory drugs, gastrointestinal medications, vitamins and nutritional supplements, cough and cold preparations, antifungals, antihistamines, and cardiovascular drugs. These products are offered in multiple dosage forms including tablets, capsules, syrups, suspensions, injections, creams, ointments, and dry powders.